U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 453 records

Showing results for "neoplasms malignant neoplasm".

  1. Nis 1999 Summarystats Core10A (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1999_SummaryStats_CORE10A.pdf
    January 01, 1999 - cancer of skin 150 0.02 24: Cancer of breast 2403 0.33 25: Cancer of uterus 755 0.10 26: Cancer of … : Cancer of prostate 2035 0.28 30: Cancer of testis 45 0.01 31: Cancer of other male genital organs … , other Unspecified primary 193 0.03 42: Secondary malignancies 5023 0.70 43: Malignant neoplasm without … 45: Maintenance chemotherapy, radiotherapy 3634 0.50 46: Benign neoplasm of uterus 4924 0.68 47: Other … unspecified benign neoplasm 3469 0.48 48: Thyroid disorders 773 0.11 49: Diabetes mellitus without

  2. Part 2: Trends in Priorities of the Heckler Report | Agency for Healthcare Research and Quality

    www.ahrq.gov/research/findings/nhqrdr/chartbooks/blackhealth/part2.html
    June 01, 2018 - Trends in Priorities of the Heckler Report Part 2: Trends in Priorities of the Heckler Report—Care for Cancer … of Mortality in Blacks 1980 2010 Diseases of the heart Diseases of the heart Malignant … neoplasm Malignant neoplasm Cerebrovascular diseases Cerebrovascular diseases Unintentional … These include cancer; cardiovascular disease and stroke; chemical dependency (measured by deaths due … Trends: All measures for infant mortality and maternity care and most measures of care for cancer

  3. Nrd 2011 Maskedstats V2 Severity (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2011_MaskedStats_V2_Severity.PDF
    January 01, 2011 - electrolyte disorders 13,915,176 0 0.00 1.00 0.21 0.40 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 13,915,176 0 0.00 1.00 0.10 0.31 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 12,699 0.09% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 18,617 0.13% 692: Radiotherapy 1,207 0.01% 693: Chemotherapy 61,609 0.44% 694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 12,416 0.09% 710: Infectious & parasitic diseases including HIV w

  4. Nrd 2010 Maskedstats Severity V2 (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2010_MaskedStats_Severity_V2.PDF
    January 01, 2010 - electrolyte disorders 13,907,610 0 0.00 1.00 0.20 0.40 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 13,907,610 0 0.00 1.00 0.10 0.30 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 12,922 0.09% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 18,995 0.14% 692: Radiotherapy 1,534 0.01% 693: Chemotherapy 61,552 0.44% 694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 12,680 0.09% 710: Infectious & parasitic diseases including HIV w

  5. Nrd 2012 Maskedstats Severity V2 (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2012_MaskedStats_Severity_V2.PDF
    January 01, 2012 - electrolyte disorders 13,459,216 0 0.00 1.00 0.21 0.41 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 13,459,216 0 0.00 1.00 0.11 0.31 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 11,811 0.09% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 7,576 0.06% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 9,897 0.07% 690 … 18,144 0.13% 692: Radiotherapy 1,115 0.01% 693: Chemotherapy 58,907 0.44% 694: Lymphatic & other malignancies

  6. Nrd 2013 Maskedstats Severity (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2013_MaskedStats_Severity.PDF
    January 01, 2013 - electrolyte disorders 14,325,172 0 0.00 1.00 0.22 0.42 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 14,325,172 0 0.00 1.00 0.11 0.32 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 11,987 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … Percent of Total 692: Radiotherapy 1,114 0.01% 693: Chemotherapy 62,706 0.44% 694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 12,072 0.08% 710: Infectious & parasitic diseases including HIV w

  7. Nis 2011 Maskedstats Severity (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2011_MaskedStats_Severity.PDF
    January 01, 2011 - electrolyte disorders 8,023,590 0 0.00 1.00 0.20 0.40 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 8,023,590 0 0.00 1.00 0.10 0.30 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 6,517 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,946 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 5,098 0.06% 690 … & neoplasms of uncertain behavior 6,509 0.08% 710: Infectious & parasitic diseases including HIV w

  8. Nis 1998 Summarystats Core10A (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1998_SummaryStats_CORE10A.PDF
    January 01, 1998 - cancer of skin 122 0.02 24: Cancer of breast 2353 0.34 25: Cancer of uterus 753 0.11 26: Cancer of … : Cancer of prostate 1733 0.25 30: Cancer of testis 37 0.01 31: Cancer of other male genital organs … , other Unspecified primary 186 0.03 42: Secondary malignancies 5145 0.75 43: Malignant neoplasm without … 45: Maintenance chemotherapy, radiotherapy 3772 0.55 46: Benign neoplasm of uterus 4448 0.65 47: Other … unspecified benign neoplasm 2893 0.42 48: Thyroid disorders 715 0.10 49: Diabetes mellitus without

  9. Com-ICD10CMChgLg-v20211-v20221 (xls file)

    hcup-us.ahrq.gov/toolssoftware/comorbidityicd10/CMR-ChangeLog-v20211-v20221.xlsx
    October 01, 2021 - (v2022.1 vs v2021.1) ICD-10-CM Code ICD-10-CM Code Description Comorbidity Measure v2022.1 C563 Malignant … neoplasm of bilateral ovaries CANCER_SOLID C7963 Secondary malignant neoplasm of bilateral ovaries

  10. Microsoft Word - CaseforPOAIndicator_final_060806 _2_.doc (pdf file)

    hcup-us.ahrq.gov/reports/methods/2006_1.pdf
    January 01, 2006 - For example, if a patient presents with a lump and it is diagnosed as a malignant neoplasm during the … hospitalization, the malignant neoplasm should be considered to be present on admission. … For example, “personal history of malignant neoplasm” cannot develop after admission. … Neoplasm Bronchus or Lung 11,303 11,244 99.48 1,311 1,302 99.3% 174.9 Malignant Neoplasm Breast 4,735 … 4,724 99.77 960 952 99.2% 185 Malignant Neoplasm Prostate 14,486 14,438 99.67 4,855 4,781 98.5% 250.00

  11. Microsoft Word - APS_DRG_Def_Public_V211.doc (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/APS-DRGs%20V21%20Definitions%20Manual.pdf
    January 13, 2015 - PROCS 172 172 DIGESTIVE MALIGNANCY 173 172 DIGESTIVE MALIGNANCY 174 174 G.I. … PROC 202 205 DISORDERS OF LIVER, EX MALIGNANCY 203 203 MALIGNANCY OF HEPATOBIL SYST OR PANCREAS … 204 204 DISORDERS OF PANCREAS EXCEPT MALIGNANCY 205 205 DISORDERS OF LIVER, EX MALIGNANCY 206 205 … 258 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY 259 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY 260 CDRG … PROC 366 366 MALIGNANCY, FEMALE REPRO SYSTEM 367 366 MALIGNANCY, FEMALE REPRO SYSTEM 368 368

  12. Microsoft Word - covtoc.doc (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/APS-DRGsV20DefinitionsManual.pdf
    January 13, 2015 - PROCS 172 172 DIGESTIVE MALIGNANCY 173 172 DIGESTIVE MALIGNANCY 174 174 G.I. … PROC 202 205 DISORDERS OF LIVER, EX MALIGNANCY 203 203 MALIGNANCY OF HEPATOBIL SYST OR PANCREAS … 204 204 DISORDERS OF PANCREAS EXCEPT MALIGNANCY 205 205 DISORDERS OF LIVER, EX MALIGNANCY 206 205 … 258 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY 259 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY 260 CDRG … PROC 366 366 MALIGNANCY, FEMALE REPRO SYSTEM 367 366 MALIGNANCY, FEMALE REPRO SYSTEM 368 368

  13. Research Protocol: Radiation Therapy for Brain Metastases (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/radiation-therapy-brain-metases-protocol.pdf
    October 10, 2019 - studies have shown that prognosis can vary substantially.5-8 Brain metastases occur with a variety of cancers … While treatment for brain metastases from other primary cancers and in pediatric patients is equally … Epidemiology of metastatic brain tumors. … Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer … OR cancer* OR neoplasm* OR carcinoma* OR metastasectomy))) AND (MH "Radiosurgery") OR TI(radiation

  14. Maskedstats Nis 2015Q1Q3 Severity (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2015Q1Q3_Severity.PDF
    November 08, 2017 - electrolyte disorders 5,377,720 0 0.00 1.00 0.22 0.42 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 5,377,720 0 0.00 1.00 0.11 0.32 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 3,979 0.07% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 2,580 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 3,152 0.06% 690 … & neoplasms of uncertain behavior 3,745 0.07% 710: Infectious & parasitic diseases including HIV w

  15. Nis 2014 Maskedstats Severity (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2014_MaskedStats_Severity.PDF
    January 01, 2014 - Variable / Label N N Miss Minimum Maximum Mean Std Dev CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 7,071,762 0 0.00 1.00 0.11 0.31 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 5,370 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,499 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 4,365 0.06% 690 … Percent of Total 692: Radiotherapy 586 0.01% 693: Chemotherapy 29,695 0.42% 694: Lymphatic & other malignancies

  16. Nis 2013 Maskedstats Severity (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2013_MaskedStats_Severity.PDF
    January 01, 2013 - Variable / Label N N Miss Minimum Maximum Mean Std Dev CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 7,119,563 0 0.00 1.00 0.10 0.30 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 5,780 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,581 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 4,512 0.06% 690 … Percent of Total 692: Radiotherapy 664 0.01% 693: Chemotherapy 30,425 0.43% 694: Lymphatic & other malignancies

  17. Kid 2012 Maskedstats Severity (pdf file)

    hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2012_MaskedStats_Severity.PDF
    January 01, 2012 - electrolyte disorders 3,195,782 0 0.00 1.00 0.08 0.27 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 3,195,782 0 0.00 1.00 0.00 0.06 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 4,907 0.15% 110: Ear, nose, mouth, throat, cranial/facial malignancies … for APRDRG APRDRG Frequency Percent of Total 693: Chemotherapy 32,305 1.01% 694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 475 0.01% 710: Infectious & parasitic diseases including HIV w O.R

  18. Maskedstats Nrd 2015Q1Q3 Severity (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2015Q1Q3_Severity.PDF
    October 31, 2017 - electrolyte disorders 12,927,179 0 0.00 1.00 0.24 0.43 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 12,927,179 0 0.00 1.00 0.12 0.33 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 9,988 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 6,987 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 8,696 0.07% 690 … Percent of Total 692: Radiotherapy 855 0.01% 693: Chemotherapy 53,580 0.41% 694: Lymphatic & other malignancies

  19. Nrd 2014 Maskedstats Severity (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2014_MaskedStats_Severity.PDF
    January 01, 2014 - electrolyte disorders 14,894,613 0 0.00 1.00 0.23 0.42 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 14,894,613 0 0.00 1.00 0.12 0.32 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 11,999 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … Percent of Total 692: Radiotherapy 1,074 0.01% 693: Chemotherapy 63,030 0.42% 694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 11,821 0.08% 710: Infectious & parasitic diseases including HIV w

  20. Nis 2012 Maskedstats Severity (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2012_MaskedStats_Severity.PDF
    January 01, 2012 - Variable / Label N N Miss Minimum Maximum Mean Std Dev CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 7,296,968 0 0.00 1.00 0.10 0.30 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 5,994 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,605 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 4,755 0.07% 690 … Percent of Total 692: Radiotherapy 706 0.01% 693: Chemotherapy 31,632 0.43% 694: Lymphatic & other malignancies
SHARE:
Facebook Twitter Print Facebook Share

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

hcup-us.ahrq.gov (323)

effectivehealthcare.ahrq.gov (60)

www.uspreventiveservicestaskforce.org (35)

www.ahrq.gov (22)

psnet.ahrq.gov (7)

digital.ahrq.gov (4)

meps.ahrq.gov (2)